PL1 - Placebo to match losmapimod tablets are tablets for oral administration and visually match the active losmapimod tablets, 15 mg., Losmapimod
1821-FSH-301
Phase 3 small_molecule active
Quick answer
PL1 - Placebo to match losmapimod tablets are tablets for oral administration and visually match the active losmapimod tablets, 15 mg., Losmapimod for Facioscapulohumeral Muscular Dystrophy (FSHD) is a Phase 3 program (small_molecule) at Fulcrum Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fulcrum Therapeutics
- Indication
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active